Nothing new under the sun: clozapine rechallenge following a life-threatening medical event in a patient with psychiatric illness and developmental disability.
Shedlack
Karen J
KJ
Department of Psychiatry, Harvard Medical School, and McLean Hospital, Belmont, MA 02478. shedlak@mcleanpo.mclean.org
Levesque
Claire
C
Charlot
Lauren
L
Bolduc
Michel
M
Silka
Van R
VR
Mikkelsen
Edwin J
EJ
Cole
Jonathan O
JO
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000150:complications* / Q000188:drug therapy / Q000628:therapy*; D001833:Body Temperature Regulation / Q000502:physiology; D003024:Clozapine / Q000009:adverse effects*; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D006801:Humans; D008607:Intellectual Disability / Q000150:complications*; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis / Q000209:etiology; D012307:Risk Factors; D012308:Risk Management
D014150:Antipsychotic Agents; D003024:Clozapine